Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRISEPTED: Radiotherapy and Steroids for Thyroid Eye Disease
NCT02339142Phase 4Unknown
- Sponsor
- University of British Columbia
- Start
- Jan 2015
- Primary completion
- Dec 2018
01
Overview
Phase 4, randomised, single-blind trial in thyroid eye disease (TED) (2 arms), sponsored by University of British Columbia. Primary endpoints: New onset dysthyroid optic neuropathy at 1 year, Progression in ocular motility dysfunction at 1 year and 1 more. Status: unknown.
02
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT02339142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02339142.